Philadelphia, PA, United States of America

Zehui Wu

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Zehui Wu in PET Imaging

Introduction

Zehui Wu is an accomplished inventor based in Philadelphia, PA, whose work has significantly impacted the field of medical imaging. With a total of four patents to his name, Wu focuses primarily on advancements in positron emission tomography (PET) imaging agents, specifically in relation to neurological disorders such as Parkinson's and Alzheimer’s disease.

Latest Patents

Wu’s latest patents involve the development of deuterium substituted positron emission tomography (PET) imaging agents. These agents are designed to evaluate conditions such as Parkinson's Disease and Alzheimer’s Disease, while also determining the activity of specific serotonin reuptake inhibitors (SSRIs) for treating depression. The inventions encompass a range of deuterated compounds represented by Formula I-A, Formula II-A, Formula II-D, and Formula III-A. Additionally, they include pharmaceutical compositions that comprise a pharmaceutically acceptable carrier combined with these innovative compounds or their acceptable salts.

Career Highlights

Zehui Wu is currently associated with Five Eleven Pharma Inc., where he continues to drive research and innovation in medical imaging technologies. His contributions not only address significant health challenges but also open avenues for further research in the pharmaceutical applications of PET imaging technologies.

Collaborations

Throughout his career, Wu has collaborated with prominent colleagues in the field, including Hank F Kung and Seok Rye Choi. These collaborations enhance the depth and breadth of research initiatives and foster the development of groundbreaking medical solutions.

Conclusion

Zehui Wu's innovative work in the realm of PET imaging agents demonstrates his commitment to improving medical diagnostics and therapeutic interventions. His patents stand as a testament to the potential of advanced imaging technologies in addressing complex neurological disorders, showcasing the vital role of inventors in the advancement of healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…